Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance.
- NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_assertion description "[Considering the possible role of Prx1 and Nrf2 in radioresistance/chemoresistance, it warrants future investigation to evaluate whether elevated Prx1 and/or Nrf2 levels are predictive of treatment response in advanced lung cancer and other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance.
- NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_assertion evidence source_evidence_literature NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance.
- NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_assertion SIO_000772 17606720 NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance.
- NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_assertion wasDerivedFrom befree-20150227 NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance.
- NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_assertion wasGeneratedBy ECO_0000203 NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance.
- befree-20150227 importedOn "2015-02-27" NP606275.RA8gTal8Lbel4lnbwsMgxUv7Wxr5C5apvoW-OVcvTbG78130_provenance.